Recent Advances and Emerging Therapies in the Management of Alzheimer’s Disease

To watch the video series component of this episode, click here.

0:00 Presentation

1:25 An overview of the current standard of care in Alzheimer’s disease

4:55 Pathophysiology of Alzheimer’s disease

6:58 Aducanumab and lecanemab for Alzheimer’s disease

9:45 Mechanism of action of anti-amyloid agents

11:19 Leaky cell theory in Alzheimer’s disease

12:35 Efficacy and safety of aducanumab and lecanemab

13:26 Safety of emerging agents in Alzheimer’s disease

16:37 Practical implementation of lecanemab

19:23 Challenges of CMS coverage for Alzheimer’s disease treatments

24:05 Effectiveness and safety of Donanemab

25:35 Overcoming clinical inertia around emerging agents of Alzheimer’s disease

29:30 A look at the future of the management of Alzheimer’s disease

31:30 Summary